These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20089869)

  • 21. Frequency and management of raised intraocular pressure following intravitreal triamcinolone acetonide.
    Mahar PS; Memon AS
    J Coll Physicians Surg Pak; 2012 Nov; 22(11):699-702. PubMed ID: 23146849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A trial of topical prednisolone acetate before intravitreal triamcinolone acetonide decreases intraocular pressure spikes.
    Hollands H; Seif G; Hollands S; Gale J
    Can J Ophthalmol; 2010 Oct; 45(5):484-8. PubMed ID: 20847754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of steroid-induced glaucoma with surgical excision of sub-Tenon triamcinolone acetonide deposits: a clinical and biochemical approach.
    Okka M; Bozkurt B; Kerimoglu H; Ozturk BT; Gunduz K; Yılmaz M; Okudan S
    Can J Ophthalmol; 2010 Dec; 45(6):621-6. PubMed ID: 20935694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of ocular hypertension in children treated with systemic glucocorticoid.
    Krag S; Larsen D; Albertsen BK; Glerup M
    Acta Ophthalmol; 2021 Dec; 99(8):e1430-e1434. PubMed ID: 33629533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
    Agrawal S; Agrawal J; Agrawal TP
    Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression and reduction of corticosteroid-induced ocular hypertension by anecortave in sheep.
    Kaufman PL
    Arch Ophthalmol; 2010 Mar; 128(3):365-6. PubMed ID: 20212210
    [No Abstract]   [Full Text] [Related]  

  • 27. Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide.
    Chan LW; Hsu WC; Hsieh YT
    J Glaucoma; 2016 Mar; 25(3):e268-72. PubMed ID: 26950466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of nocturnal elevation of intraocular pressure by gene transfer of dominant-negative RhoA in rats.
    Borrás T; Buie LK; Spiga MG; Carabana J
    JAMA Ophthalmol; 2015 Feb; 133(2):182-90. PubMed ID: 25412195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension.
    Roddy GW; Chowdhury UR; Monson KJ; Fautsch MP
    Curr Eye Res; 2021 Oct; 46(10):1525-1530. PubMed ID: 33757401
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term Outcomes on de novo Ocular Hypertensive Response to Topical Corticosteroids After Corneal Transplantation.
    Raj A; Salvador-Culla B; Anwar H; Sykakis E; Figueiredo MS; Figueiredo FC
    Cornea; 2020 Jan; 39(1):45-51. PubMed ID: 31517723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraocular Pressure after Intravitreal Triesence Injection.
    Atchison EA; Bakri SJ
    Semin Ophthalmol; 2018; 33(3):308-312. PubMed ID: 27935332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ID1 and ID3 are Negative Regulators of TGFβ2-Induced Ocular Hypertension and Compromised Aqueous Humor Outflow Facility in Mice.
    Mody AA; Millar JC; Clark AF
    Invest Ophthalmol Vis Sci; 2021 May; 62(6):3. PubMed ID: 33938911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of dorzolamide/timolol versus brimonidine/timolol fixed combination therapy in the management of steroid-induced ocular hypertension.
    Seymenoğlu G; Baser EF; Öztürk B; Gülhan C
    J Glaucoma; 2015 Feb; 24(2):111-6. PubMed ID: 23807349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection.
    Breusegem C; Vandewalle E; Van Calster J; Stalmans I; Zeyen T
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):573-6. PubMed ID: 18824737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection in a Chinese population.
    Lau LI; Chen KC; Lee FL; Chen SJ; Ko YC; Liu CJ; Hsu WM
    Am J Ophthalmol; 2008 Oct; 146(4):573-578. PubMed ID: 18639860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term intraocular pressure trends after intravitreal triamcinolone injection.
    Lee EW; Hariprasad SM; Mieler WF; Newman TL; Apte RS
    Am J Ophthalmol; 2007 Feb; 143(2):365-7. PubMed ID: 17258540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraocular pressure after intravitreal injection of triamcinolone acetonide.
    Jonas JB; Kreissig I; Degenring R
    Br J Ophthalmol; 2003 Jan; 87(1):24-7. PubMed ID: 12488256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases.
    Wykrota AA; Abdin AD; Munteanu C; Löw U; Seitz B
    Graefes Arch Clin Exp Ophthalmol; 2023 Dec; 261(12):3569-3579. PubMed ID: 37432451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of intraocular pressure elevation after anterior versus posterior subtenon triamcinolone acetonide acetate injection: a retrospective study.
    Liu X; Li Y; Zhang Y; Du W; Sun S; Lin B; Chen H; Cheng L
    Retina; 2012 Oct; 32(9):1838-43. PubMed ID: 22487579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
    Roth DB; Verma V; Realini T; Prenner JL; Feuer WJ; Fechtner RD
    Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.